Home Cart 0 Sign in  
X

[ CAS No. 1111637-74-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1111637-74-1
Chemical Structure| 1111637-74-1
Chemical Structure| 1111637-74-1
Structure of 1111637-74-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1111637-74-1 ]

Related Doc. of [ 1111637-74-1 ]

Alternatived Products of [ 1111637-74-1 ]

Product Details of [ 1111637-74-1 ]

CAS No. :1111637-74-1 MDL No. :MFCD12024449
Formula : C7H5BrFNO Boiling Point : -
Linear Structure Formula :- InChI Key :NTEVXGZFBVJCAP-UHFFFAOYSA-N
M.W : 218.02 Pubchem ID :40151906
Synonyms :

Calculated chemistry of [ 1111637-74-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 42.09
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.45 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.56
Log Po/w (XLOGP3) : 1.66
Log Po/w (WLOGP) : 2.61
Log Po/w (MLOGP) : 1.31
Log Po/w (SILICOS-IT) : 2.75
Consensus Log Po/w : 1.98

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.58
Solubility : 0.58 mg/ml ; 0.00266 mol/l
Class : Soluble
Log S (Ali) : -1.9
Solubility : 2.73 mg/ml ; 0.0125 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.5
Solubility : 0.0691 mg/ml ; 0.000317 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.82

Safety of [ 1111637-74-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1111637-74-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1111637-74-1 ]
  • Downstream synthetic route of [ 1111637-74-1 ]

[ 1111637-74-1 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 1111637-73-0 ]
  • [ 1111637-74-1 ]
YieldReaction ConditionsOperation in experiment
100% With dipyridinium dichromate In dichloromethane at 0 - 20℃; for 48 h; A solution of pyridinium dichromate (55.4 g, 147 mmol) in DCM (100 mL) was brought to 0° C. and a solution of 1-(5-bromo-2-fluoropyridin-3-yl)ethanol (10.8 g, 49.1 mmol) in DCM (30 mL) was added. The reaction was allowed to warmed to room temperature and stirred for 48 h. The mixture was filtered through Celite, washed with DCM and concentrated to afford 1-(5-bromo-2-fluoropyridin-3-yl)ethanone (11 g, 51 mmol, 100percent yield) as a light yellow solid. LC/MS (ESI+) m/z=218 (M+H
70.2% With tetrapropylammonium perruthennate; 4-methylmorpholine N-oxide In dichloromethane; acetonitrile at 20℃; l -(5 jrorao~2~flero-3-pyrtdyl)tHiiaoe: To a solution of the above compound (3.15 g, 14.32 mmol, L0 eq.) in DCM (95.5 m'L) and MeCN (9.5 mL) was added 4-meihyiroor}?hohne N-oxide (6.71 g, 57.26 mmol, 4.0 eq.) followed by tetrapropylammonium perrumenate (251.54 mg, 0.72 mmol, 0.5 eq.). The reaction mixture was stirred at rt until completion by TLC. The mixture was filtered through a pad of Celtic which, was washed with DCM. Solvents were removed under reduced pressure. The crude residue was purified using flash chromatography (0-30percent EtOAc/hexanes) to provide the title compound (2) as a white crystalline solid (2.19 g, 70.2percent yield). TLC (25percent EiQAe/hexanes): f - 0.58; H NMR (400 MHz, CDCIj) 3 8.46-8.43 (m, 2H), 2.70 (d, J - 4.7 Hz, 3H).
63% With dipyridinium dichromate In dichloromethane at 0 - 20℃; Step 3:76 77To a mixture of PDC (365 g, 0.97 mol) and CH2CI2 (2000 mL) was added compound 76 (85 g, 0.39 mol) at O0C. After the addition, the reaction mixture was warmed up to room temperature and stirred overnight. TLC (petroleum ether/EtOAc 10:1) indicated the reaction was complete. The resulting mixture was filtered and the filtrate was concentrated in vacuo to give crude compound 77, which was purified by column chromatography (silica gel, petroleum ether/EtOAc 50:1 ) to yield pure compound 77 (56 g, 63percent) as a yellow solid.
Reference: [1] Patent: US2014/213581, 2014, A1, . Location in patent: Paragraph 0684
[2] Patent: WO2016/123629, 2016, A1, . Location in patent: Paragraph 0214
[3] Patent: WO2009/16460, 2009, A2, . Location in patent: Page/Page column 54
[4] Patent: US2014/107109, 2014, A1, . Location in patent: Page/Page column
[5] Patent: US2014/107109, 2014, A1, . Location in patent: Page/Page column
[6] Journal of Medicinal Chemistry, 2017, vol. 60, # 14, p. 6018 - 6035
  • 2
  • [ 766-11-0 ]
  • [ 78191-00-1 ]
  • [ 1111637-74-1 ]
YieldReaction ConditionsOperation in experiment
44.6%
Stage #1: With n-butyllithium; N-ethyl-N,N-diisopropylamine In tetrahydrofuran at -78 - -65℃; for 1 h; Inert atmosphere
Stage #2: at -78℃; for 1 h; Inert atmosphere
Preparative Example 7 Step 1: l-(5-bromo-2-fluoropyridin-3-yl)ethanone To a solution of diisopropylamine (46.3 g, 458.4 mmol) in tetrahydrofuran (lOOOmL) was added butyllithium (176 mL, 440 mmol, 2.5 M) at -78 °C under nitrogen. After addition, the reaction mixture was stirred for 30 min at -78 °C. 5-bromo-2-fluoropyridine (86.7 g, 442.3 mmol) was added (keeping the temperature under -65 °C). After addition, the mixture was stirred for 1 h. N-methoxy- N-methylacetamide (50 g, 485.4 mmol) was added and stirred at -78 °C for 1 h. The reaction mixture was quenched with water (lOOOmL), extracted with ethyl acetate (3 x 500 mL), washed with brine, dried over sodium sulfate and concentrated to dryness in vacuo. The resulting residue was purified by column chromatography (silica gel, 100-200 mesh, 0.5percent ethyl acetate in petroleum ether) affording 1- (5-bromo-2-fluoropyridin-3-yl)ethanone (43 g, 44.6 percent): H NMR (400 MHz, Chloroform-d): δ 8.46- 8.42 (m, 2H), 2.70 (s, 3H).
Reference: [1] Patent: WO2016/142310, 2016, A1, . Location in patent: Page/Page column 68
[2] Patent: WO2015/187437, 2015, A1, . Location in patent: Page/Page column 59
  • 3
  • [ 875781-15-0 ]
  • [ 1111637-74-1 ]
Reference: [1] Patent: US2014/107109, 2014, A1,
[2] Patent: US2014/213581, 2014, A1,
[3] Patent: WO2016/123629, 2016, A1,
[4] Journal of Medicinal Chemistry, 2017, vol. 60, # 14, p. 6018 - 6035
  • 4
  • [ 766-11-0 ]
  • [ 1111637-74-1 ]
Reference: [1] Patent: US2014/107109, 2014, A1,
  • 5
  • [ 1111637-74-1 ]
  • [ 1111637-76-3 ]
Reference: [1] Patent: WO2016/142310, 2016, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1111637-74-1 ]

Fluorinated Building Blocks

Chemical Structure| 875781-15-0

[ 875781-15-0 ]

5-Bromo-2-fluoronicotinaldehyde

Similarity: 0.88

Chemical Structure| 128071-77-2

[ 128071-77-2 ]

4-Bromo-2-fluoronicotinaldehyde

Similarity: 0.77

Chemical Structure| 1883347-28-1

[ 1883347-28-1 ]

1-(5-Bromopyridin-3-yl)-2,2,2-trifluoroethanone hydrochloride

Similarity: 0.76

Chemical Structure| 29312-98-9

[ 29312-98-9 ]

5-Bromo-2-fluoro-3-methylpyridine

Similarity: 0.75

Chemical Structure| 1211526-51-0

[ 1211526-51-0 ]

5-Bromo-2-methyl-3-(trifluoromethyl)pyridine

Similarity: 0.65

Bromides

Chemical Structure| 875781-15-0

[ 875781-15-0 ]

5-Bromo-2-fluoronicotinaldehyde

Similarity: 0.88

Chemical Structure| 38940-62-4

[ 38940-62-4 ]

3-Acetyl-5-bromopyridine

Similarity: 0.79

Chemical Structure| 128071-77-2

[ 128071-77-2 ]

4-Bromo-2-fluoronicotinaldehyde

Similarity: 0.77

Chemical Structure| 1883347-28-1

[ 1883347-28-1 ]

1-(5-Bromopyridin-3-yl)-2,2,2-trifluoroethanone hydrochloride

Similarity: 0.76

Chemical Structure| 1256823-89-8

[ 1256823-89-8 ]

1-(5-Bromo-2-methylpyridin-3-yl)ethanone

Similarity: 0.75

Ketones

Chemical Structure| 38940-62-4

[ 38940-62-4 ]

3-Acetyl-5-bromopyridine

Similarity: 0.79

Chemical Structure| 1883347-28-1

[ 1883347-28-1 ]

1-(5-Bromopyridin-3-yl)-2,2,2-trifluoroethanone hydrochloride

Similarity: 0.76

Chemical Structure| 1256823-89-8

[ 1256823-89-8 ]

1-(5-Bromo-2-methylpyridin-3-yl)ethanone

Similarity: 0.75

Chemical Structure| 59105-50-9

[ 59105-50-9 ]

(5-Bromopyridin-3-yl)(phenyl)methanone

Similarity: 0.73

Chemical Structure| 886365-47-5

[ 886365-47-5 ]

1-(5-Bromo-2-chloropyridin-3-yl)ethanone

Similarity: 0.70

Related Parent Nucleus of
[ 1111637-74-1 ]

Pyridines

Chemical Structure| 875781-15-0

[ 875781-15-0 ]

5-Bromo-2-fluoronicotinaldehyde

Similarity: 0.88

Chemical Structure| 38940-62-4

[ 38940-62-4 ]

3-Acetyl-5-bromopyridine

Similarity: 0.79

Chemical Structure| 128071-77-2

[ 128071-77-2 ]

4-Bromo-2-fluoronicotinaldehyde

Similarity: 0.77

Chemical Structure| 1883347-28-1

[ 1883347-28-1 ]

1-(5-Bromopyridin-3-yl)-2,2,2-trifluoroethanone hydrochloride

Similarity: 0.76

Chemical Structure| 1256823-89-8

[ 1256823-89-8 ]

1-(5-Bromo-2-methylpyridin-3-yl)ethanone

Similarity: 0.75